Evernorth Government and Healthcare Products and services Field Leader Joan Harvey Named to PAVmed Board of Directors

NEW YORK–(Company WIRE)–PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a diversified industrial-stage medical engineering enterprise and parent of most cancers avoidance business Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”), now announced the appointment of notable healthcare products and services industry leader and president of Care Options for Evernorth, Joan Harvey, to its Board of Administrators. Ms. Harvey will serve as a member of the Company’s Audit and Compensation Committees.

“Ms. Harvey brings a wealth of health and fitness treatment working experience, sturdy track file in strategic and enterprise progress, and deep economic acumen to our board,” explained Lishan Aklog M.D., PAVmed’s chairman and chief executive officer. “She shares our enthusiasm for implementing ground breaking technologies and treatment types to increase health outcomes, and her contributions will be invaluable as we travel professional advancement, grow our medical services—including our community of diagnostic test centers—and associate with payors.”

“PAVmed’s groundbreaking wellbeing systems mixed with their potent medical and analysis teams have incredible potential to propel the well being treatment field forward,” claimed Ms. Harvey. “Their merchandise have the skill to change how we avert, diagnose, and treat some of the most complicated and debilitating conditions. I glance ahead to contributing to PAVmed’s ongoing achievements and transformation into a top world wide clinical technology business.”

Ms. Harvey has more than two a long time of overall health treatment practical experience serving in a wide variety of leadership roles devoted to bettering entire individual wellness and advocating for people. She is the president of Treatment Alternatives for Evernorth, Cigna Corporation’s (NYSE: CI) well being expert services organization. In this position, she oversees Evernorth’s professional medical, behavioral, and pharmacy medical plans to satisfy the numerous wants of overall health strategies, companies, government organizations—and the persons they serve.

Prior to signing up for Evernorth, Ms. Harvey served in senior management roles at Cigna, Medco Overall health Remedies Inc., WellPoint 360 Overall health. a subsidiary of Anthem, Inc., American Imaging Management, and Oxford Health and fitness Plans, LLC, a subsidiary of UnitedHealth Group. She is a founding member of the Illness Administration Association of The usa, and author of “Asthma Disease Administration in the 21st Century” for the Managed Treatment Handbook: Finest Techniques in Health care Management. Ms. Harvey holds a Master of Business enterprise Administration from the American Graduate College of International Administration and a Bachelor’s degree in International Relations from Bates College.

About PAVmed

PAVmed Inc. is a diversified commercial-phase healthcare technologies firm functioning in the medical gadget, diagnostics, and electronic wellness sectors. Its big subsidiary, Lucid Diagnostics Inc. (Nasdaq: LUCD), marketplaces the EsoGuard^® Esophageal DNA Check and EsoCheck^® Esophageal Cell Collection Device—the to start with and only industrial equipment for prevalent early detection of esophageal precancer to avert esophageal most cancers fatalities. One more major subsidiary, Veris Health and fitness Inc., is a electronic overall health business developing the first intelligent implantable vascular access port with biologic sensors and wireless conversation to improve individualized cancer treatment by way of remote individual monitoring. PAVmed’s CarpX^® Minimally Invasive Device for Carpal Tunnel Syndrome is presently in restricted commercial release. The solution pipeline also contains the EsoCure™ Esophageal Ablation Device with Caldus™ Engineering, which complements EsoGuard and EsoCheck, the NextFlo™ Intravenous Infusion Established, the PortIO™ Implantable Intraosseous Vascular Accessibility Machine, novel pediatric ear tubes, mechanical circulatory assist know-how and glucose monitoring. For more data, remember to pay a visit to www.pavmed.com, comply with us on Twitter, connect with us on LinkedIn, and look at our films on YouTube. For a lot more information on our vast majority owned subsidiary, Lucid Diagnostics Inc., you should check out www.luciddx.com, abide by Lucid on Twitter, and hook up with Lucid on LinkedIn. For detailed information and facts on EsoGuard, please pay a visit to www.EsoGuard.com and observe us on Twitter, Facebook and Instagram.

Forward-Looking Statements

This push launch includes ahead-hunting statements that include hazard and uncertainties. Ahead-on the lookout statements are any statements that are not historical points. This sort of ahead-seeking statements, which are based upon the present-day beliefs and anticipations of PAVmed’s administration, are topic to threats and uncertainties, which could induce genuine results to vary from the forward-looking statements. Pitfalls and uncertainties that may lead to these types of variances contain, amongst other factors, volatility in the selling price of PAVmed’s popular stock PAVmed’s Sequence W and Collection Z warrants normal financial and industry conditions the uncertainties inherent in investigation and enhancement, which includes the cost and time expected to progress PAVmed’s products to regulatory submission whether or not regulatory authorities will be content with the style of and effects from PAVmed’s scientific and preclinical scientific tests irrespective of whether and when PAVmed’s products are cleared by regulatory authorities market place acceptance of PAVmed’s and products and solutions as soon as cleared and commercialized PAVmed’s skill to increase further funding as desired and other aggressive developments. In addition, PAVmed has been checking the COVID-19 pandemic and the pandemic’s affect on PAVmed’s enterprises. PAVmed expects the significance of the COVID-19 pandemic, like the extent of its impact on its money and operational benefits, to be dictated by, between other factors, the accomplishment of efforts to contain the pandemic and the impact of these endeavours on PAVmed’s businesses. These things are hard or extremely hard to forecast accurately and numerous of them are further than PAVmed’s management. In addition, new challenges and uncertainties may well occur from time to time and are hard to forecast. For a additional list and description of these and other vital dangers and uncertainties that may well have an impact on PAVmed’s foreseeable future functions, see Part I, Item IA, “Risk Elements,” in PAVmed’s most latest Annual Report on Type 10-K submitted with the Securities and Trade Commission, as the very same may possibly be current in Component II, Product 1A, “Risk Factors” in any Quarterly Report on Form 10-Q submitted by PAVmed immediately after its most modern Once-a-year Report submitted with the Securities and Exchange Commission. PAVmed disclaims any intention or obligation to publicly update or revise any forward-searching statement to mirror any alter in its expectations or in occasions, problems, or circumstances on which people expectations may well be dependent, or that may possibly have an effect on the likelihood that actual results will vary from these contained in the ahead-looking statements.